Although the mRNA expression of ISX strongly correlates with those of BRD4 and PCAF in patients with HCC, denoting that they were co‐expressed in liver cancer cells, the interaction between ISX, BRD4, and PCAF remains to be at issue. This evidence concerns the gene KAT2B and hepatocellular carcinoma.